ALTIBODY
Live / Applied — Second extension granted (statement of use) (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 16 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97127774
- Mark type
- Stylized text
- Filed
- 16 Nov 2021
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of genetically-engineered antibodies for others
- Class 042 — Scientific and technological services: Genetic engineering services, namely, scientific laboratory services in the nature of the production of genetically-engineered antibodies for others for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Genetic engineering services, namely, the production of genetically-engineered antibodies for others for medical diagnostic or medical treatment purposes
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — SOU EXTENSION 2 GRANTED
- 11 Mar 2026 — SOU EXTENSION 2 FILED
- 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2025 — SOU EXTENSION 1 GRANTED
- 22 Aug 2025 — SOU EXTENSION 1 FILED
- 22 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED